Shanghai Haohai Biological Technology Co., Ltd. (6826.HK)
HKD 26.85
(-1.65%)
HKD 26.85
(-1.65%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.63 Billion | 2.1 Billion | 1.75 Billion | 1.32 Billion | 1.59 Billion | 1.54 Billion |
| Cost of Revenue | 781.4 Million | 656.51 Million | 490.37 Million | 334 Million | 363.99 Million | 334.28 Million |
| Gross Profit | 1.85 Billion | 1.44 Billion | 1.25 Billion | 990.42 Million | 1.23 Billion | 1.21 Billion |
| Operating Expenses | 1.41 Billion | 1.22 Billion | 1.03 Billion | 865.07 Million | 929.18 Million | 768.41 Million |
| Selling, General and Administrative Expenses | 1.23 Billion | 1.08 Billion | 898.43 Million | 772.48 Million | 813.11 Million | 737.48 Million |
| Research and Development Expenses | 220.09 Million | 182.19 Million | 167.59 Million | 126.47 Million | 116.07 Million | 95.37 Million |
| Other Expenses | -41.82 Million | -40.27 Million | -33.88 Million | -33.88 Million | 107.74 Million | 341 Thousand |
| Cost and Expenses | 2.19 Billion | 1.88 Billion | 1.52 Billion | 1.19 Billion | 1.29 Billion | 1.1 Billion |
| Operating Income | 438.37 Million | 258.66 Million | 384.43 Million | 260.56 Million | 437.96 Million | 443.12 Million |
| Interest Expense | 7.29 Million | 7.6 Million | 4.96 Million | 4.9 Million | 4.53 Million | 2.14 Million |
| Income Tax Expense | 95.99 Million | 45.39 Million | 35.36 Million | 30.68 Million | 57.97 Million | 70.1 Million |
| Earnings before Tax | 508.26 Million | 235.72 Million | 382.64 Million | 257.02 Million | 434.34 Million | 525.18 Million |
| Net Income | 416.12 Million | 180.47 Million | 352.23 Million | 230.07 Million | 370.77 Million | 414.54 Million |
| Earnings Per Share Basic | 1.24 | 1.04 | 2.00 | 1.30 | 2.27 | 2.59 |
| Earnings Per Share Diluted | 1.24 | 1.04 | 2.00 | 1.30 | 2.27 | 2.59 |
| Weighted Average Shares Outstanding | 334.26 Million | 173.52 Million | 176.12 Million | 176.97 Million | 163.01 Million | 160.04 Million |
| Weighted Average Shares Outstanding (Diluted) | 334.26 Million | 173.56 Million | 176.12 Million | 177.23 Million | 163.01 Million | 160.04 Million |
| Gross Margin | 0.70 | 0.69 | 0.72 | 0.75 | 0.77 | 0.78 |
| EBIT Margin | 0.27 | 0.22 | 0.31 | 0.30 | 0.35 | 0.40 |
| Profit Margin | 0.16 | 0.09 | 0.20 | 0.17 | 0.23 | 0.27 |
| EBITDA | 713.41 Million | 447.54 Million | 550.44 Million | 394.8 Million | 554.31 Million | 610.94 Million |
| Earnings Before Tax Margin | 0.17 | 0.12 | 0.22 | 0.20 | 0.27 | 0.29 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 758.44 Million | 645.99 Million | 2.63 Billion | 653.12 Million | 676.08 Million | 694.45 Million |
| Cost of Revenue | 215.23 Million | 198.87 Million | 781.4 Million | 219.5 Million | 182.6 Million | 205.04 Million |
| Gross Profit | 543.2 Million | 447.12 Million | 1.85 Billion | 433.61 Million | 493.47 Million | 489.41 Million |
| Operating Expenses | 393.72 Million | 346.09 Million | 1.41 Billion | 309.99 Million | 400.98 Million | 364.27 Million |
| Selling, General and Administrative Expenses | 205.92 Million | 199.34 Million | - | 297.71 Million | 317.55 Million | 421.2 Million |
| Research and Development Expenses | 60.5 Million | 64.9 Million | - | 65.94 Million | 52.76 Million | 47.76 Million |
| Other Expenses | -36.07 Thousand | -262.85 Thousand | -4.03 Million | -4.77 Million | 5.55 Million | -5.64 Million |
| Cost and Expenses | 608.96 Million | 544.97 Million | 2.19 Billion | 529.49 Million | 583.59 Million | 569.31 Million |
| Operating Income | 148.36 Million | 114.42 Million | 512.95 Million | 116.85 Million | 138.92 Million | 101.72 Million |
| Interest Expense | 4.85 Million | 2.67 Million | 7.29 Million | 2.73 Million | 889.32 Thousand | 2.62 Million |
| Income Tax Expense | 23.15 Million | 21.67 Million | 95.99 Million | 33.6 Million | 21.27 Million | 13.96 Million |
| Earnings before Tax | 148.32 Million | 114.16 Million | 508.26 Million | 118.91 Million | 139.55 Million | 137.7 Million |
| Net Income | 137.74 Million | 97.54 Million | 416.12 Million | 89.31 Million | 121.56 Million | 124.05 Million |
| Earnings Per Share Basic | 0.82 | 0.58 | - | 0.52 | 0.71 | 0.60 |
| Earnings Per Share Diluted | 0.82 | 0.58 | - | 0.52 | 0.71 | 0.60 |
| Weighted Average Shares Outstanding | 168.7 Million | 168.7 Million | 170.53 Million | 170.68 Million | 170.83 Million | 171.23 Million |
| Weighted Average Shares Outstanding (Diluted) | 168.7 Million | 168.7 Million | 170.53 Million | 170.68 Million | 170.83 Million | 171.23 Million |
| Gross Margin | 0.72 | 0.69 | 0.70 | 0.66 | 0.73 | 0.70 |
| EBIT Margin | 0.22 | 0.18 | - | 0.18 | 0.21 | 0.20 |
| Profit Margin | 0.18 | 0.15 | 0.16 | 0.14 | 0.18 | 0.18 |
| EBITDA | 165.12 Million | 117.24 Million | - | 116.85 Million | 138.92 Million | 142.2 Million |
| Earnings Before Tax Margin | 0.20 | 0.18 | 0.19 | 0.18 | 0.21 | 0.15 |
PRIME
MFC-PB
JBNK
6176
603026
NUFMF